Aster DM Healthcare is currently trading at Rs. 153.75, up by 5.15 points or 3.47% from its previous closing of Rs. 148.60 on the BSE.
The scrip opened at Rs. 153.00 and has touched a high and low of Rs. 154.60 and Rs. 148.25 respectively. So far 3211 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 169.00 on 21-Jan-2019 and a 52 week low of Rs. 109.70 on 07-Aug-2019.
Last one week high and low of the scrip stood at Rs. 158.40 and Rs. 141.30 respectively. The current market cap of the company is Rs. 7646.62 crore.
The promoters holding in the company stood at 37.80%, while Institutions and Non-Institutions held 17.63% and 44.57% respectively.
Aster DM Healthcare is planning to make a foray into the diagnostics segment in order to scale up business in the country. The Kochi-based firm, which has a sizeable presence across GCC (Gulf Cooperation Council) states, plans to have around 40 standalone diagnostics laboratories in India over the next two years, with the first two outlets expected to come up in Bengaluru in the fourth quarter.
The company plans to have laboratories mainly in Karnataka and Kerala in the first phase, and in the next financial year, establish outlets in Andhra Pradesh, Telangana, Tamil Nadu, and Maharashtra. The company would also look at strategic acquisitions to expand this business and additional capital will be deployed accordingly.
Aster DM Healthcare operates as a healthcare company in the Middle East, India, and the Far East. It operates hospitals and clinics, pharmacies, diagnostic centers, educational institutions, and healthcare management and healthcare support systems.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: